| pubmed-article:12946753 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12946753 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12946753 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:12946753 | lifeskim:mentions | umls-concept:C0138741 | lld:lifeskim |
| pubmed-article:12946753 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
| pubmed-article:12946753 | lifeskim:mentions | umls-concept:C1366489 | lld:lifeskim |
| pubmed-article:12946753 | lifeskim:mentions | umls-concept:C1417779 | lld:lifeskim |
| pubmed-article:12946753 | lifeskim:mentions | umls-concept:C0016694 | lld:lifeskim |
| pubmed-article:12946753 | lifeskim:mentions | umls-concept:C0242792 | lld:lifeskim |
| pubmed-article:12946753 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:12946753 | lifeskim:mentions | umls-concept:C0392752 | lld:lifeskim |
| pubmed-article:12946753 | lifeskim:mentions | umls-concept:C1708760 | lld:lifeskim |
| pubmed-article:12946753 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:12946753 | pubmed:dateCreated | 2003-8-29 | lld:pubmed |
| pubmed-article:12946753 | pubmed:abstractText | To determine whether the post-external beam radiotherapy (RT) prostate-specific antigen nadir (nPSA) improves our ability to predict freedom from PSA failure, progression-free survival (PFS), and overall survival. Controversy regarding the importance of nPSA after external beam RT as a prognostic indicator for patients with localized prostate cancer has continued. | lld:pubmed |
| pubmed-article:12946753 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12946753 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12946753 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12946753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12946753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12946753 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12946753 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:12946753 | pubmed:issn | 1527-9995 | lld:pubmed |
| pubmed-article:12946753 | pubmed:author | pubmed-author:WeinbergVV | lld:pubmed |
| pubmed-article:12946753 | pubmed:author | pubmed-author:SandlerH MHM | lld:pubmed |
| pubmed-article:12946753 | pubmed:author | pubmed-author:RoachMM3rd | lld:pubmed |
| pubmed-article:12946753 | pubmed:author | pubmed-author:McLaughlinP... | lld:pubmed |
| pubmed-article:12946753 | pubmed:author | pubmed-author:DeWittK DKD | lld:pubmed |
| pubmed-article:12946753 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:12946753 | pubmed:volume | 62 | lld:pubmed |
| pubmed-article:12946753 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12946753 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12946753 | pubmed:pagination | 492-6 | lld:pubmed |
| pubmed-article:12946753 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:meshHeading | pubmed-meshheading:12946753... | lld:pubmed |
| pubmed-article:12946753 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12946753 | pubmed:articleTitle | What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer? | lld:pubmed |
| pubmed-article:12946753 | pubmed:affiliation | Department of Radiation Oncology, University of California, San Francisco, School of Medicine, 94143-1708, USA. | lld:pubmed |
| pubmed-article:12946753 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12946753 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12946753 | lld:pubmed |
